Third Pole Therapeutics's last reported valuation, Mar 2025. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Third Pole Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Third Pole Therapeutics funding history
No funding rounds for Third Pole Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Third Pole Therapeutics valuation
Third Pole Therapeutics's last reported valuation was $240 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.
How Third Pole Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Third Pole Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Third Pole Therapeutics
- What is Third Pole Therapeutics worth?
- Third Pole Therapeutics is valued at $240.0M as of Oct 2026. Third Pole Therapeutics's last reported valuation, Mar 2025. Nothing priced has surfaced since.
- How much has Third Pole Therapeutics raised?
- Third Pole Therapeutics has raised $125.8M in total funding across its recorded rounds.